The Nutshell

» NIH and disease/medicine

Daily News Roundup

Most Recent

image: Some Insurers Protected by GINA

Some Insurers Protected by GINA

By | January 23, 2013

Long-term, life, and disability insurers may still be able to deny coverage to patients with a genetic disease, under current nondiscrimination legislation.

2 Comments

image: First Recombinant Flu Vaccine

First Recombinant Flu Vaccine

By | January 21, 2013

The US Food and Drug Administration approves the first flu vaccine made from recombinant proteins rather than a weakened virus.

1 Comment

image: Dung Defeats Drugs

Dung Defeats Drugs

By | January 18, 2013

Fecal transplants outcompeted traditional antibiotics at curing a deadly intestinal infection.

0 Comments

image: Misconduct Apology

Misconduct Apology

By | January 18, 2013

A neurodegenerative disease researcher found guilty of fabricating results in funding applications has written an open letter of apology and clarification.

0 Comments

image: Repoopulation Remedy

Repoopulation Remedy

By | January 9, 2013

Transplanting synthetic stool made of beneficial microbes cures deadly diarrheal infections in two patients.

1 Comment

image: The End of Days for H5N1 Moratorium?

The End of Days for H5N1 Moratorium?

By | December 21, 2012

Experts in Washington have reached an agreement over how to fund avian influenza research.

0 Comments

image: Losing the Funding Fight

Losing the Funding Fight

By | December 11, 2012

A researcher tries and fails to garner support for petitions to increase the National Institutes of Health’s budget as sequestration looms.

1 Comment

image: Maggot Medicine

Maggot Medicine

By | December 10, 2012

The healing powers of maggots may lie in their secreted proteins, which restrain the human immune response.

2 Comments

image: Drug Approvals Up

Drug Approvals Up

By | December 7, 2012

The total number of new drugs approved this year ties last year for the highest since 2004, suggesting that the pharmaceutical industry is recovering.  

0 Comments

image: Hurry Up, FDA

Hurry Up, FDA

By | December 6, 2012

The US Food and Drug Administration is taking steps to get new devices on the market sooner—and antibiotics may be next.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

  4. Another DNA Vaccine for Zika Shows Promise
RayBiotech